IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1925 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7069    
    Printed159    
    Emailed4    
    PDF Downloaded277    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2003  |  Volume : 69  |  Issue : 4  |  Page : 287--288

Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor


Department of Skin, VD and Leprosy, Pt. B. D. S. Postgraduate Institute of Medical Sciences, Rohtak - 124001, India

Correspondence Address:
V K Jain
11/9J, Medical Enclave, Pt. BDS PGIMS, Rohtak - 124001
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17642914

Rights and PermissionsRights and Permissions

Introduction: Both topical and systemic ketoconazole are reported to be effective against pityriasis versicolor. Material and Methods: Forty patients suffering from pityriasis versicolor were treated either with oral ketoconazole 200 mg per day or 2% ketoconazole cream topically once daily for 2 weeks. Results: On global assessment, after 2 weeks of start of therapy, 18 (90%) out of 20 patients treated with oral ketoconazole were cured while 2 patients had considerable residual disease. In the ketoconazole cream group, 16 (80%) out of 20 patients were cured and 4 patients had considerable residual disease. Conclusion: No significant difference was observed in the response rates in the two groups. Relapse occurred in two patients of the systemic ketoconazole group and six patients of the topical ketoconazole group during the follow-up period of three months.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow